Search

Your search keyword '"Charbit, Bruno"' showing total 138 results

Search Constraints

Start Over You searched for: Author "Charbit, Bruno" Remove constraint Author: "Charbit, Bruno"
138 results on '"Charbit, Bruno"'

Search Results

1. Increased levels of GM-CSF and CXCL10 and low CD8+ memory stem T Cell count are markers of immunosenescence and severe COVID-19 in older people

3. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

4. Integrated analysis of whole blood oxylipin and cytokine responses after bacterial, viral, and T cell stimulation reveals new immune networks

8. Defective activation and regulation of type I interferon immunity is associated with increasing COVID-19 severity

10. A monocyte/dendritic cell molecular signature of SARS-CoV-2-related multisystem inflammatory syndrome in children with severe myocarditis

12. Platelet activation in critically ill COVID-19 patients

13. Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients

14. Increased levels of GM-CSF and CXCL10 and low CD8+ memory stem T Cell count are markers of immunosenescence and severe COVID-19 in older people.

17. Integrated analysis of whole blood oxylipin and cytokine responses after bacterial, viral and T-cell stimulation reveals new immune networks

18. Systemic immunosuppression depletes peripheral blood regulatory B cells in patients with immune thrombocytopenia.

19. Tuberculosis alters immune-metabolic pathways resulting in perturbed IL-1 responses

20. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

22. Variability of Primary Sjögren's Syndrome Is Driven by Interferon α and Interferon α Blood Levels Are Associated With the Class II HLA–DQ Locus

23. Variability in primary Sjögren's syndrome is driven by interferon alpha, and genetically associated with the class II HLA DQ locus

24. Defective type I interferon immunity is associated with increasing COVID-19 severity

25. The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies

26. Additional file 2 of Integrative genetic and immune cell analysis of plasma proteins in healthy donors identifies novel associations involving primary immune deficiency genes

27. Severe COVID-19 is associated with hyperactivation of the alternative complement pathway

29. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

30. X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19

31. Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infection

32. Safety of sitagliptin in treatment of hepatocellular carcinoma in chronic liver disease patients

33. Immune checkpoint inhibitors increase T cell immunity during SARS-CoV-2 infection

34. Additional file 1 of Platelet activation in critically ill COVID-19 patients

35. Additional file 2 of Platelet activation in critically ill COVID-19 patients

37. Distinct systemic and mucosal immune responses to SARS-CoV-2

38. Immune profiling enables stratification of patients with active TB disease or M. tuberculosis infection

39. Antibody-coated microbiota in nasopharynx of healthy individuals and hypogammaglobulinemia patients

40. Associations between untargeted plasma metabolomic signatures and gut microbiota composition in the Milieu Intérieur population of healthy adults

41. Early IFNβ Secretion Determines Variable Downstream IL-12p70 Responses Upon TLR4 Activation

42. A Monocyte/Dendritic Cell Molecular Signature of SARS-CoV-2 Related Multisystem Inflammatory Syndrome in Children (MIS-C) with Severe Myocarditis

43. Tuberculosis alters immune-metabolic pathways resulting in perturbed IL-1 responses

44. Dysregulated primary hemostasis in critically ill COVID-19 patients

45. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

46. Impaired type I interferon activity and exacerbated inflammatory responses in severe Covid-19 patients

47. Control of TLR7-mediated type I IFN signaling in pDCs through CXCR4 engagement—A new target for lupus treatment

48. Immune Profiling Enables Stratification of Patients With Active Tuberculosis Disease or Mycobacterium tuberculosis Infection.

49. Associations between untargeted plasma metabolomic signatures and gut microbiota composition in the Milieu Intérieur population of healthy adults.

50. Additional file 2: of Human genetic variants and age are the strongest predictors of humoral immune responses to common pathogens and vaccines

Catalog

Books, media, physical & digital resources